Clinical Trial Update: Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease [Phase 1, Phase 2]

View source ↗

Summary

Recruitment is underway for a Phase 1/2 trial of EN-374 gene therapy in patients with X-Linked Chronic Granulomatous Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Chronic Granulomatous Disease

Drugs mentioned

• EN-374

Snippet

Sponsor: Ensoma | Conditions: X-Linked Chronic Granulomatous Disease | Phase 1, Phase 2 | Status: RECRUITING